No record found
No record found
* Returns not adjusted for payouts
Company Profile
The Company was incorporated in Pakistan in 1967 as a Public Limited Company under Companies Act, 1913 (now Companies Act, 2017). The Company is a subsidiary of Sanofi Foreign Participations B.V. registered in Netherlands. The ultimate parent of the Company is Sanofi S.A., France. The Company is engaged in the manufacturing, selling and trading of pharmaceutical and related products.
FAMCO Associates (Pvt) Ltd 8-F, Next to Hotel Faran, Nursery, Block -6, P.E.C.H.S Shahrah e Faisal Karachi
A. F. Ferguson & Co. Chartered Accountants
December
Equity Profile
Announcements
Date | Title | Document |
---|---|---|
Oct 30, 2023 | Transmission of Financial Statements for the Nine-Months Period Ended September 30, 2023 | View PDF |
Oct 23, 2023 | Financial Results for the Period Ended September 30, 2023 | View PDF |
Aug 29, 2023 | Transmission of Financial Statements for the Half Year Ended June 30, 2023 | View PDF |
Aug 25, 2023 | Financial Results for the Half Year Ended June 30, 2023 | View PDF |
May 31, 2023 | Transmission of Quarterly Report for the Period Ended March 31, 2023 | View PDF |
May 30, 2023 | Financial Results for the Period Ended March 31, 2023 | View PDF |
May 3, 2023 | Transmission of Annual Report for the Year Ended 2022-12-31 | View PDF |
Apr 20, 2023 | Financial Results for the Year Ended December 31, 2022 | View PDF |
Mar 29, 2023 | Applied for Extension for Holding the AGM for the Year Ended December 31, 2022 | View PDF |
Oct 28, 2022 | Transmission of Financial Statements for the period ended September 30, 2022 | View PDF |
Date | Title | Document |
---|---|---|
Oct 13, 2023 | BOARD MEETING AND ANNOUNCEMENT OF CLOSED PERIOD | View PDF |
Sep 5, 2023 | CERTIFIED TRUE COPY OF THE RESOLUTIONS PASSED IN THE EXTRAORDINARY GENERAL MEETING OF SANOFI-AVENTIS PAKISTAN LIMITED U/C 5.6.9(b) OF THE PSX RULE BOOK | View PDF |
Aug 17, 2023 | BOARD MEETING AND ANNOUNCEMENT OF CLOSED PERIOD | View PDF |
Aug 16, 2023 | Notice of Extraordinary General Meeting | View PDF |
Aug 15, 2023 | Notice of Extraordinary General Meeting (Pre-Publication) | View PDF |
Aug 9, 2023 | Information about Date and Time for Holding the Extraordinary General Meeting | View PDF |
Aug 1, 2023 | BOARD MEETING AND ANNOUNCEMENT OF BOOK CLOSURE | View PDF |
May 25, 2023 | CERTIFIED TRUE COPY OF THE RESOLUTIONS PASSED IN THE ANNUAL GENERAL MEETING OF SANOFI-AVENTIS PAKISTAN LIMITED U/C 5.6.9 (b) OF THE PSX RULE BOOK | View PDF |
May 23, 2023 | BOARD MEETING FOR THE PERIOD ENDED MARCH 31, 2023 | View PDF |
May 3, 2023 | Notice of Annual General Meeting | View PDF |
Date | Title | Document |
---|---|---|
Oct 2, 2023 | Approval of Change of Name | View PDF |
Sep 28, 2023 | APPOINTMENT OF DIRECTOR | View PDF |
Sep 5, 2023 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | View |
Aug 29, 2023 | PUBLICATION OF NOTICE OF BALLOT PAPER UNDER REGULATION 8 OF THE COMPANIES (POSTAL BALLOT) REGULATIONS, 2018 | View PDF |
Aug 28, 2023 | Notice of Ballot Paper for Voting Through Post (Pre-Publication) | View PDF |
Aug 9, 2023 | Disclosure of Material Information | View PDF |
Jul 27, 2023 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | View |
Jul 26, 2023 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations REVOKED | View |
Jun 13, 2023 | Appointment of Chief Executive Officer | View PDF |
Jun 12, 2023 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | View |
Financials
All numbers in thousands (000's) except EPS
2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|
Sales | 18,559,884 | 15,880,932 | 14,107,802 | 14,500,678 |
Profit after Taxation | 166,783 | 905,952 | 493,067 | 154,836 |
EPS | 17.29 | 93.93 | 51.12 | 16.05 |
Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | |
---|---|---|---|---|
Sales | 5,831,380 | 5,285,241 | 4,762,608 | 4,521,404 |
Profit after Taxation | 469,498 | (165,187) | (357,143) | 24,155 |
EPS | 48.68 | (17.13) | (37.03) | 2.50 |
Ratios
2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|
Gross Profit Margin (%) | 26.24 | 25.96 | 26.97 | 25.69 |
Net Profit Margin (%) | 0.90 | 5.70 | 3.49 | 1.07 |
EPS Growth (%) | (81.59) | 83.74 | 218.50 | (74.74) |
PEG | (0.68) | 0.11 | 0.07 | (0.69) |
Payouts
Date | Financial Results | Details | Book Closure |
---|---|---|---|
March 25, 2022 3:38 PM | 31/12/2021(YR) | 300%(F) (D) | 17/04/2022 - 25/04/2022 |
March 2, 2021 2:59 PM | 31/12/2020(YR) | 200%(F) (D) | 13/04/2021 - 23/04/2021 |
March 3, 2020 3:51 PM | 31/12/2019(YR) | 80% (D) | 13/05/2020 - 20/05/2020 |
March 1, 2019 1:38 PM | 31/12/2018(YR) | 300% (F) (D) | 17/04/2019 - 23/04/2019 |
March 7, 2018 3:01 PM | 31/12/2017(YR) | 450% (D) | 20/04/2018 - 26/04/2018 |
March 8, 2017 12:53 PM | 31/12/2016(YR) | 300% (D) | 19/04/2017 - 25/04/2017 |
February 25, 2016 10:14 AM | 31/12/2015(YR) | 30% (D) | 19/04/2016 - 25/04/2016 |
March 12, 2015 1:37 PM | 31/12/2014(YR) | 70% (D) | 21/04/2015 - 27/04/2015 |
February 26, 2014 2:19 PM | 31/12/2013(YR) | 100% (D) | 18/04/2014 - 25/04/2014 |
February 28, 2013 10:15 AM | 31/12/2012(YR) | 125% (F) (D) | 19/04/2013 - 25/04/2013 |